These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1623255)

  • 41. [Experimental models, of Parkinson disease].
    Luquin MR
    Rev Neurol; 2000 Jul 1-15; 31(1):60-6. PubMed ID: 10948587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic aspects of the behavior of MPTP and some analogues.
    Tipton KF; McCrodden JM; Sullivan JP
    Adv Neurol; 1993; 60():186-93. PubMed ID: 8420134
    [No Abstract]   [Full Text] [Related]  

  • 43. Olfactory impairment and Parkinson's disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Miwa T; Watanabe A; Mitsumoto Y; Furukawa M; Fukushima N; Moriizumi T
    Acta Otolaryngol Suppl; 2004 Aug; (553):80-4. PubMed ID: 15277042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathophysiology of Parkinson's disease.
    Bonnet AM; Houeto JL
    Biomed Pharmacother; 1999 Apr; 53(3):117-21. PubMed ID: 10349507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.
    Jenner P
    Acta Neurol Scand Suppl; 1993; 146():6-13. PubMed ID: 8333254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidative stress as a cause of Parkinson's disease.
    Jenner P
    Acta Neurol Scand Suppl; 1991; 136():6-15. PubMed ID: 1801537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress.
    Abdulwahid Arif I; Ahmad Khan H
    Toxicol Ind Health; 2010 Mar; 26(2):121-8. PubMed ID: 20207656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides.
    Dardiotis E; Xiromerisiou G; Hadjichristodoulou C; Tsatsakis AM; Wilks MF; Hadjigeorgiou GM
    Toxicology; 2013 May; 307():17-23. PubMed ID: 23295711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monkey model of Parkinson's disease.
    Kolata G
    Science; 1983 May; 220(4598):705. PubMed ID: 6403987
    [No Abstract]   [Full Text] [Related]  

  • 50. Parkinson's disease: an environmental cause?
    Lewin R
    Science; 1985 Jul; 229(4710):257-8. PubMed ID: 3925554
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pathophysiology of Parkinson's disease: an update].
    Tremblay L
    Bull Acad Natl Med; 2010 Oct; 194(7):1321-31; discussion 1331-2. PubMed ID: 22043627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transplantation advances in Parkinson's disease.
    Sladek JR; Redmond DE; Collier TJ; Elsworth JD; Roth RH
    Mov Disord; 1989; 4 Suppl 1():S120-5. PubMed ID: 2786143
    [No Abstract]   [Full Text] [Related]  

  • 53. Nigral degeneration in Parkinson's disease.
    Rinne JO
    Mov Disord; 1993; 8 Suppl 1():S31-5. PubMed ID: 8302305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fetal-tissue transplants in Parkinson's disease.
    Fahn S
    N Engl J Med; 1992 Nov; 327(22):1589-90. PubMed ID: 1435887
    [No Abstract]   [Full Text] [Related]  

  • 55. Human striatal recordings reveal abnormal discharge of projection neurons in Parkinson's disease.
    Singh A; Mewes K; Gross RE; DeLong MR; Obeso JA; Papa SM
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9629-34. PubMed ID: 27503874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine and basal ganglia.
    Hikosaka O
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):511. PubMed ID: 1762258
    [No Abstract]   [Full Text] [Related]  

  • 57. Trail of ironies to Parkinson's disease.
    Lewin R
    Science; 1984 Jun; 224(4653):1083-5. PubMed ID: 6426059
    [No Abstract]   [Full Text] [Related]  

  • 58. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease.
    Mizuno Y; Ikebe S; Hattori N; Nakagawa-Hattori Y; Mochizuki H; Tanaka M; Ozawa T
    Biochim Biophys Acta; 1995 May; 1271(1):265-74. PubMed ID: 7599219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease.
    Ayton S; Lei P; Duce JA; Wong BX; Sedjahtera A; Adlard PA; Bush AI; Finkelstein DI
    Ann Neurol; 2013 Apr; 73(4):554-9. PubMed ID: 23424051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Mitochondrial DNA and Parkinson disease. Methodologic review].
    Pautot V; Macaigne C; Chariot P
    Arch Anat Cytol Pathol; 1998; 46(4):261-8. PubMed ID: 9754389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.